In a move that should markedly enhance the market opportunities for Qualyst’s B-Clear hepatocyte research kits and contract services, the company has agreed with Invitrogen to offer hepatocyte screening services and research products through the latter’s wholly-owned subsidiary, CellzDirect.
Theratechnologies Inc. and EMD Serono Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced the companies entered a collaboration and licensing agreement for the exclusive commercialization rights to tesamorelin in the United States for the treatment of excess abdominal fat in HIV patients with lipodystrophy.
It’s pretty hard to be the editor of a business publication and not address the recent world-wide economic meltdown. What’s to make of this mess, and what are the potential impacts on the biotech and pharmaceutical industry?
Twenty years ago, life in Big Pharma was genteel and secure. Today, it is neither. There are always good career opportunities for the best, and the only way to be the best is to get to work and not wait for miracles.
Just as our editorial staff delivers the news to our readers, our sales staff delivers integrated marketing opportunities to the advertising community. DDN is very fortunate that in our fourth year, we have a veteran sales team, all of whom have deep and significant experience in life science publishing, to help our advertisers design their own customized integrated marketing programs.